News & Analysis on Clinical Trial Services & Contract Research And Development
CRO Quintiles last week announced its fourth consecutive quarter of at least $1B in net new business, as well as 13% growth in the second quarter of this year, though analysts said the company did not meet bookings expectations.
The Supreme Court of India late last week ordered all state government health secretaries to meet with the national Secretary of the Ministry of Health to discuss ways to strengthen the framework for regulating clinical trials.
Kemwell has positioned a foothold in the US with the acquisition of drug delivery research firm Cirrus Pharmaceuticals.
Vivus has selected Sanofi Chimie to manufacture the API for its ED drug due to price and capacity, the company says.
EMD Millipore says while voluntary excipient quality schemes are step in the right direction, formal GMP and enforcement would create a level playing field.
CRO INC Research opened two new locations in Osaka and Tokyo, Japan, to further expand the company’s reach to conduct trials in the highly sought-after Asian region.